Recurrent Infection
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients (NCT06306014) | Hospices Civils de Lyon | 2024-05-07 |
Track Recurrent Infection automatically
Every clearance here is in the API, with alerts when new ones post.